Upregulation of cardiac insulin-like growth factor-I receptor by ACE inhibition after myocardial infarction: Potential role in remodeling

Journal of Histochemistry and Cytochemistry

Volumn 51, Issue 6, 2003, Pages 831-839

  Dean, Rachael G ^a   Bach, Leon A ^a   Burrell, Louise M ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

ACE inhibitors; Cellular; Experimental; Gene expression; Growth factors; Heart; Hormones; Infarction; Pathophysiology

Indexed keywords

CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE REGULATION; BODY WEIGHT; CELL VIABILITY; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; FEMALE; GENE EXPRESSION REGULATION; HEART INFARCTION; HEART INFARCTION SIZE; HEART VENTRICLE REMODELING; HEMODYNAMICS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT; RECEPTOR UPREGULATION;

ANIMALIA; TRIXIS;

EID: 0038351028     PISSN: 00221554     EISSN: None     Source Type: Journal    
DOI: 10.1177/002215540305100614     Document Type: Article

References (40)

1. Anversa P, Kajstura J (1998) Myocyte cell death in the diseased heart. Circ Res 82:1231-1233
2. Bach LA, Rechler MM (1995) Insulin-like growth factor binding proteins. Diabetes Rev 3:38-61
3. Battler A, Hasdai D, Goldberg I, Ohad D, Di Segni E, Bor A, Varda-Bloom N, et al. (1995) Exogenous insulin-like growth factor II enhances post-infarction regional myocardial function in swine. Eur Heart J 16:1851-1859
4. Brink M, Delafontaine P (1995) Angiotensin II stimulates insulin-like growth factor I gene expression in rat heart. Circulation 92:I-61a
5. Buerke M, Murohara T, Skurk C, Nuss C, Tomaselli K, Lefer AM (1995) Cardioprotective effect of insulin-like growth factor I in myocardial ischemia followed by reperfusion. Proc Natl Acad Sci USA 92:8031-8035
6. Burrell LM, Chan R, Phillips P, Calafiore P, Tonkin A, Johnston CI (1996) Validation of an echocardiographic assessment of cardiac function following moderate size myocardial infarction in the rat. Clin Exp Pharmacol Physiol 23:570-572
7. Burrell LM, Farina NK, Balding LC, Johnston CI (2000) Beneficial renal and cardiac effects of vasopeptidase inhibition with S21402 in heart failure. Hypertension 36:1105-1111
8. Burrell LM, Phillips PA, Risvanis J, Chan RK, Aldred K, Johnston CI (1998) Long-term effects of non-peptide vasopressin V2 antagonist OPC-31260 in heart failure in the rat. Am J Physiol 275:H176-182
9. Cohn J. (1995) Structural basis for heart failure. Circulation 91:2503-2507
10. Conti E, Andreotti F, Sciahbasi A, Riccardi P, Marra G, Menini E, Ghirlanda G, et al. (2001) Markedly reduced insulin-like growth factor-1 in the acute phase of myocardial infarction. J Am Coll Cardiol 38:26-32
11. Dean R, Edmondson SR, Burrell LM, Bach LA (1999) Localization of the insulin-like growth factor system in a rat model of heart failure induced by myocardial infarction. J Histochem Cytochem 47:649-660
12. Donath M, Zapf J, Eppenberger EM, Froesch E, Eppenberger H (1994) Insulin-like growth factor-I stimulates myofibril development and decreases smooth muscle alpha-actin of adult cardiomyocytes. Proc Natl Acad Sci USA 91:1686-1690
13. Duerr RL, Huang S, Miraliakbar HR, Clark R, Chien KR, Ross J Jr (1995) Insulin-like growth factor-1 enhances ventricular hypertrophy and function during the onset of experimental cardiac failure. J Clin Invest 95:619-627
14. Duncan AM, Burrell LM, Kladis A, Campbell DJ (1996) Effects of angiotensin-converting enzyme inhibition on angiotensin and bradykinin peptides in rats with myocardial infarction. J Cardiovasc Pharmacol 28:746-754
15. Duncan A-M, Burrell LM, Kladis A, Campbell DJ (1997) Angiotensin and bradykinin peptides in rats with myocardial infarction. J Card Failure 3:41-52
16. Fazio S, Sabatini D, Capaldo B, Vigorito C, Giordano A, Guida R, Pardo F, et al. (1996) A preliminary study of growth hormone in the treatment of dilated cardiomyopathy. N Engl J Med 334:809-814
17. Genth-Zotz S, Zotz R, Geil S, Voigtlander T, Meyer J, Darius H (1999) Recombinant human growth hormone therapy in patients with ischaemic cardiomyopathy: effects of haemodynamics, left ventricular function and cardiopulmonary exercise capacity. Circulation 99:18-21
18. Goussev A, Sharov VG, Shimoyama H, Tanimura M, Lesch M, Goldstein S, Sabbah HN (1998) Effects of ACE inhibition on cardiomyocyte apoptosis in dogs with heart failure. Am J Physiol 274:H626-631
19. Granata R, Broglio F, Migliorino D, Cutrupi S, Baldanzi G, Sireno M, Fubini A, et al. (2000) Neonatal and adult human heart tissues from normal subjects and patients with ischemic, dilated or hypertrophic cardiomyopathy express insulin-like growth factor binding protein-3 (IGFBP-3). J Endocrinol Invest 23:724-726
20. James JD, Hauer-Jensen M (1999) Effects of fixative and fixation time for quantitative computerised image analysis of immunohistochemical staining. J Histotechnol 22:109-111
21. Jin HY, Wang ZN (2001) Insulin-like growth factors and their receptors in human fallopian tube in reproductive-age women. Fertil Steril 75:1037-1038
22. Jin H, Yang R, Gillett N, Clark RG, Ko A, Paoni NF (1995) Beneficial effects of growth hormone and insulin-like growth factor-1 in experimental heart failure in rats treated with chronic ACE inhibition. J Cardiovasc Pharmacol 26:420-425
23. Le Moine C, Bernard V, Bloch B (1994) Quantitative in situ hybridization using radioactive probes in the study of gene expression in heterocellular systems. In Choo KHA, ed. Methods in Molecular Biology: In Situ Hybridization Protocols. Vol 33. Totowa, NJ, Humana Press, 301-311
24. Lee W-L, Chen J-W, Ting C-T, Lin S-J, Wang P-H (1999) Changes of the IGF system during myocardial infarction. Implications on left ventricular remodeling. J Clin Endocrinol Metab 84:1575-1581
25. Leri A, Liu Y, Claudio PP, Kajstura J, Wang X, Wang S, Kang P, Malhorta A, Anversa P (1999) Insulin-like growth factor-I induces Mdm2 and down-regulates p53, attenuating the myocyte renin-angiotensin system and stretch mediated apoptosis. Am J Pathol 154:567-580
26. Li R-K, Li G, Mickle DAG, Weisel RD, Merante F, Luss H, Rao V, Christakis GT, Williams WG (1997) Overexpression of transforming growth factor-B1 and insulin-like growth factor-I in patients with idiopathic hypertrophic cardiomyopathy. Circulation 96:874-881
27. Loennechen JP, Stoylen A, Beisvag V, Wisloff U, Ellingsen O (2001) Regional expression of endothelin-1, ANP, IGF-1, and LV wall stress in the infarcted rat heart. Am J Physiol 280:H2902-2910
28. Omerovic E, Bollano E, Mobini R, Kujacic V, Madhu B, Soussi B, Fu M, et al. (2000) Growth hormone improves bioenergetics and decreases catecholamines in postinfarct rat hearts. Endocrinology 141:4592-4599
29. Osterziel KJ, Strohm O, Schuler J, Friedrich M, Hanlein D, Willenbrock R, Anker SD, et al. (1998) Randomised, double-blind, placebo-controlled trial of human recombinant growth hormone in patients with chronic heart failure due to dilated cardiomyopathy. Lancet 351:1233-1236
30. Passier RC, Smits JF, Verluyten MJ, Daemen MJ (1996) Expression and localization of renin and angiotensinogen in rat heart after myocardial infarction. Am J Physiol 271:H1040-1048
31. Pfeffer M, Braunwald E, Moye L, Basta L, Brown EJ, Cuddy T, Davis B, et al. (1992) Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. N Engl J Med 327:669-677
32. Pfeffer MA, Pfeffer JM, Steinberg C, Finn P (1985) Survival after an experimental myocardial infarction: beneficial effects of longterm therapy with captopril. Circulation 72:406-412
33. Reiss K, Meggs LG, Li P, Olivetti G, Capasso JM, Anversa P (1994) Upregulation of IGF-1, IGF-1 receptor, and late growth related genes in ventricular myocytes acutely after infarction in rats. J Cell Physiol 158:160-168
34. Resnicoff M, Burgaud JL, Rotman HL, Abraham D, Baserga R (1995) Correlation between apoptosis, tumorigenesis, and levels of insulin-like growth factor-I receptors. Cancer Res 55:3739-3741
35. Rimsza LM, Rangel CS, Grogran TM (1999) Image analysis for quantitative evalustion of antigen retrieval efficacy demonstrates increased detection of P-glycoprotein in overfixed cells but decreased detection in optimally fixed cells. J Histotechnology 22:9-14
36. Wang L, Ma W, Markovich R, Lee W-L, Wang PH (1998) Insulin-like growth factor-I modulates induction of apoptotic signaling in H9C2 cardiac muscle cells. Endocrinology 139:1354-1360
37. Welch S, Plank D, Witt S, Glascock B, Schaefer E, Chimenti S, Andreoli A M, et al. (2002) Cardiac-specific IGF-1 expression attenuates dilated cardiomyopathy in tropomodulin-overexpressing transgenic mice. Circ Res 90:641-648
38. Yamada H, Fabris B, Allen AM, Jackson B, Johnston CI, Mendelsohn FAO (1991) Localization of angiotensin converting enzyme in rat heart. Circ Res 68:1491-1499
39. Yamamura T, Otani H, Nakao Y, Hattori R, Osako M, Imamura H (2001) IGF-I differentially regulates Bcl-xL and Bax and confers myocardial protection in the rat heart. Am J Physiol 280:H1191-1200
40. Yang R, Bunting S, Gillett N, Clark R, Jin H (1995) Growth hormone improves cardiac performance in experimental heart failure. Circulation 92:262-267